Dr. Neil Shear graduated with a degree in Engineering Science from the University of Toronto in 1973 and earned his medical degree at McMaster University, Hamilton, in 1976. Dr. Shear completed training in both internal medicine and dermatology recognized by the Royal College of Physicians and Surgeons of Canada and the American Boards. He also completed a fellowship in Clinical Pharmacology, supported by the Medical Research Council of Canada, at the Hospital for Sick Children in Toronto. Dr. Shear joined the staff of Sunnybrook Hospital in Toronto in 1984 and is now the Head of Dermatology at Sunnybrook & Women’s College Health Sciences Centre and the Director of the University of Toronto Drug Safety Research Group. Dr Shear founded the Drug Safety Clinic at Sunnybrook in 1985 and was the founding chair of the Canadian Adverse Drug Reaction Advisory Committee (CADRAC) of Health Canada.
Dr. Shear has conducted numerous clinical trials in dermatology, from first in human early pharmacology studies to large randomized trials of novel therapeutics, and he is Vice President of Research and Development (Dermatology) at Ventana Clinical Research. His research has been funded by numerous peer-reviewed agencies and the pharmaceutical industry. Dr. Shear’s main interest is in idiosyncratic drug reactions that involve the skin. He has published 300 peer reviewed papers and numerous chapters and abstracts. His clinical interests are diverse, from rosacea and camouflage makeup to autoimmune blistering diseases. Dr. Shear is a past president of the Canadian Society for Clinical Pharmacology and a recipient of the society’s Distinguished Service Award. He is Chair of the Canadian Association of Professors of Dermatology, President of the Canadian Dermatology Foundation, and a member of the prestigious American Dermatology Association. He was the founding editor of the Canadian Journal of Clinical Pharmacology and is the associate editor of the Journal of Cutaneous Medicine and Surgery and deputy editor of Journal Watch Dermatology.